tiprankstipranks
Kuros Biosciences Ltd. (CH:KURN)
:KURN

Compare Kuros Biosciences (KURN) vs. Competitors

8 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Kuros Biosciences
CHF28.16
CHF959.35M
498.59
38.55%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF136.47M
-2.50
9.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF664.04M
16.63
36.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.43
CHF891.34M
-8.17
253.46%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF15.04
CHF309.59M
-9.69
141.80%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF16.64
CHF236.25M
-0.98
25.49%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:KURN
Kuros Biosciences
24.44
7.03
40.38%
CH:MOLN
Molecular Partners AG
3.38
0.15
4.48%
CH:BSLN
Basilea Pharmaceutica
54.50
15.05
38.15%
CH:IDIA
Idorsia Ltd
3.52
2.49
240.81%
CH:NWRN
Newron Pharmaceuticals SpA
15.04
9.01
149.42%
CH:SANN
Santhera Pharmaceuticals Holding
16.64
3.82
29.80%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts